166 related articles for article (PubMed ID: 11302475)
1. Epsilon-aminocaproic acid promotes the release of alpha2-antiplasmin during and after cardiopulmonary bypass.
Ray MJ; Hales M; Marsh N
Blood Coagul Fibrinolysis; 2001 Mar; 12(2):129-35. PubMed ID: 11302475
[TBL] [Abstract][Full Text] [Related]
2. Antifibrinolytic therapy during cardiopulmonary bypass reduces proinflammatory cytokine levels: a randomized, double-blind, placebo-controlled study of epsilon-aminocaproic acid and aprotinin.
Greilich PE; Brouse CF; Whitten CW; Chi L; Dimaio JM; Jessen ME
J Thorac Cardiovasc Surg; 2003 Nov; 126(5):1498-503. PubMed ID: 14666025
[TBL] [Abstract][Full Text] [Related]
3. High-dose epsilon-aminocaproic acid versus aprotinin: antifibrinolytic efficacy in first-time coronary operations.
Eberle B; Mayer E; Hafner G; Heinermann J; Dahm M; Prellwitz W; Dick W; Oelert H
Ann Thorac Surg; 1998 Mar; 65(3):667-73. PubMed ID: 9527193
[TBL] [Abstract][Full Text] [Related]
4. Systematic elucidation of effects of tranexamic acid on fibrinolysis and bleeding during and after cardiopulmonary bypass surgery.
Kojima T; Gando S; Morimoto Y; Mashio H; Goda Y; Kawahigashi H; Kemmotsu O
Thromb Res; 2001 Dec; 104(5):301-7. PubMed ID: 11738071
[TBL] [Abstract][Full Text] [Related]
5. Suppressed fibrinolysis after administration of low-dose aprotinin: reduced level of plasmin-alpha2-plasmin inhibitor complexes and postoperative blood loss.
Mastroroberto P; Chello M; Zofrea S; Marchese AR
Eur J Cardiothorac Surg; 1995; 9(3):143-5. PubMed ID: 7540397
[TBL] [Abstract][Full Text] [Related]
6. Postoperatively administered aprotinin or epsilon aminocaproic acid after cardiopulmonary bypass has limited benefit.
Ray MJ; Hales MM; Brown L; O'Brien MF; Stafford EG
Ann Thorac Surg; 2001 Aug; 72(2):521-6. PubMed ID: 11515892
[TBL] [Abstract][Full Text] [Related]
7. Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost.
Ray MJ; O'Brien MF
Ann Thorac Surg; 2001 Mar; 71(3):838-43. PubMed ID: 11269462
[TBL] [Abstract][Full Text] [Related]
8. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
[TBL] [Abstract][Full Text] [Related]
9. Increased urokinase and consumption of α
Longstaff C; Locke M
J Thromb Haemost; 2019 Jan; 17(1):195-205. PubMed ID: 30451372
[TBL] [Abstract][Full Text] [Related]
10. Laboratory measures of hemostasis and fibrinolysis after intravenous administration of epsilon-aminocaproic acid in clinically normal horses and ponies.
Heidmann P; Tornquist SJ; Qu A; Cebra CK
Am J Vet Res; 2005 Feb; 66(2):313-8. PubMed ID: 15757133
[TBL] [Abstract][Full Text] [Related]
11. A Pharmacokinetic and Pharmacodynamic Investigation of an ε-Aminocaproic Acid Regimen Designed for Cardiac Surgery With Cardiopulmonary Bypass.
Strauss ER; Dahmane E; Judd M; Guo D; Williams B; Meyer M; Gammie JS; Taylor B; Mazzeffi MA; Gobburu JVS; Tanaka KA
J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):406-417. PubMed ID: 32811752
[TBL] [Abstract][Full Text] [Related]
12. Aprotinin but not epsilon-aminocaproic acid decreases interleukin-10 after cardiac surgery with extracorporeal circulation: randomized, double-blind, placebo-controlled study in patients receiving aprotinin and epsilon-aminocaproic acid.
Greilich PE; Okada K; Latham P; Kumar RR; Jessen ME
Circulation; 2001 Sep; 104(12 Suppl 1):I265-9. PubMed ID: 11568067
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of plasmin inhibition by aprotinin in vivo.
Kang HM; Kalnoski MH; Frederick M; Chandler WL
Thromb Res; 2005; 115(4):327-40. PubMed ID: 15668193
[TBL] [Abstract][Full Text] [Related]
14. The effect of epsilon-aminocaproic acid and aprotinin on fibrinolysis and blood loss in patients undergoing primary, isolated coronary artery bypass surgery: a randomized, double-blind, placebo-controlled, noninferiority trial.
Greilich PE; Jessen ME; Satyanarayana N; Whitten CW; Nuttall GA; Beckham JM; Wall MH; Butterworth JF
Anesth Analg; 2009 Jul; 109(1):15-24. PubMed ID: 19535691
[TBL] [Abstract][Full Text] [Related]
15. Co-administration of aprotinin and epsilon-aminocaproic acid during cardiopulmonary bypass in a swine model.
Vang SN; Stammers AH; Mejak BL; Rauch ED; Viessman TW; Bruda NL; Yang T
J Extra Corpor Technol; 2000 Dec; 32(4):196-206. PubMed ID: 11194056
[TBL] [Abstract][Full Text] [Related]
16. Negative reexploration for cardiac postoperative bleeding: can it be therapeutic?
Pelletier MP; Solymoss S; Lee A; Chiu RC
Ann Thorac Surg; 1998 Apr; 65(4):999-1002. PubMed ID: 9564917
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of epsilon-aminocaproic acid and aprotinin on matrix metalloproteinase release in patients following cardiopulmonary bypass.
Dorman BH; Stroud RE; Wyckoff MM; Zellner JL; Botta D; Leonardi AH; Ikonomidis JS; Spinale FG
J Cardiovasc Pharmacol; 2008 Apr; 51(4):418-23. PubMed ID: 18427286
[TBL] [Abstract][Full Text] [Related]
18. Aprotinin reduces blood loss after cardiopulmonary bypass by direct inhibition of plasmin.
Ray MJ; Marsh NA
Thromb Haemost; 1997 Sep; 78(3):1021-6. PubMed ID: 9308747
[TBL] [Abstract][Full Text] [Related]
19. Clotting and fibrinolytic disturbance during lung transplantation: effect of low-dose aprotinin. Groningen Lung Transplant Group.
Gu YJ; de Haan J; Brenken UP; de Boer WJ; Prop J; Van Oeveren W
J Thorac Cardiovasc Surg; 1996 Sep; 112(3):599-606. PubMed ID: 8800145
[TBL] [Abstract][Full Text] [Related]
20. Contribution of endogenous bradykinin to fibrinolysis, inflammation, and blood product transfusion following cardiac surgery: a randomized clinical trial.
Balaguer JM; Yu C; Byrne JG; Ball SK; Petracek MR; Brown NJ; Pretorius M
Clin Pharmacol Ther; 2013 Apr; 93(4):326-34. PubMed ID: 23361105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
